Cellebrite DI (CLBT) Competitors $16.36 -0.04 (-0.24%) Closing price 04:00 PM EasternExtended Trading$16.44 +0.08 (+0.49%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLBT vs. DUOL, DOCU, DT, TEM, PAYC, YMM, DOCS, SNAP, IONQ, and MBLYShould you be buying Cellebrite DI stock or one of its competitors? The main competitors of Cellebrite DI include Duolingo (DUOL), Docusign (DOCU), Dynatrace (DT), Tempus AI (TEM), Paycom Software (PAYC), Full Truck Alliance (YMM), Doximity (DOCS), Snap (SNAP), IonQ (IONQ), and Mobileye Global (MBLY). These companies are all part of the "computer software" industry. Cellebrite DI vs. Its Competitors Duolingo Docusign Dynatrace Tempus AI Paycom Software Full Truck Alliance Doximity Snap IonQ Mobileye Global Duolingo (NASDAQ:DUOL) and Cellebrite DI (NASDAQ:CLBT) are both computer software companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Which has more risk & volatility, DUOL or CLBT? Duolingo has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Do institutionals and insiders believe in DUOL or CLBT? 91.6% of Duolingo shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 18.3% of Duolingo shares are owned by insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts recommend DUOL or CLBT? Duolingo presently has a consensus price target of $451.35, indicating a potential upside of 55.65%. Cellebrite DI has a consensus price target of $22.40, indicating a potential upside of 36.92%. Given Duolingo's higher possible upside, research analysts clearly believe Duolingo is more favorable than Cellebrite DI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Duolingo 0 Sell rating(s) 6 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.68Cellebrite DI 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DUOL or CLBT more profitable? Duolingo has a net margin of 13.24% compared to Cellebrite DI's net margin of -34.56%. Cellebrite DI's return on equity of 23.92% beat Duolingo's return on equity.Company Net Margins Return on Equity Return on Assets Duolingo13.24% 13.32% 8.57% Cellebrite DI -34.56%23.92%11.94% Which has higher valuation and earnings, DUOL or CLBT? Duolingo has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Duolingo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDuolingo$885.15M15.01$88.57M$2.43119.33Cellebrite DI$436.73M8.97-$283.01M-$0.76-21.53 Does the media favor DUOL or CLBT? In the previous week, Duolingo had 27 more articles in the media than Cellebrite DI. MarketBeat recorded 40 mentions for Duolingo and 13 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.68 beat Duolingo's score of 0.72 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Duolingo 18 Very Positive mention(s) 5 Positive mention(s) 13 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Cellebrite DI 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryDuolingo beats Cellebrite DI on 11 of the 16 factors compared between the two stocks. Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLBT vs. The Competition Export to ExcelMetricCellebrite DIINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$3.92B$19.18B$29.73B$9.68BDividend YieldN/A3.40%3.18%4.54%P/E Ratio-21.5378.15416.8626.40Price / Sales8.9763.341,677.44204.59Price / Cash44.9087.5034.3228.92Price / Book10.048.277.006.06Net Income-$283.01M$355.31M$808.51M$266.05M7 Day Performance3.54%0.14%-0.34%-0.07%1 Month Performance19.42%3.02%3.79%5.83%1 Year Performance-4.10%58.23%24,000.39%17.89% Cellebrite DI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLBTCellebrite DI3.2747 of 5 stars$16.36-0.2%$22.40+36.9%-3.9%$3.92B$436.73M-21.531,167News CoverageShort Interest ↑DUOLDuolingo4.3123 of 5 stars$321.44-3.1%$451.35+40.4%+40.1%$15.21B$748.02M132.28600Analyst DowngradeGap DownDOCUDocusign4.8633 of 5 stars$73.94-1.2%$89.77+21.4%+29.5%$15.12B$2.98B13.986,838Positive NewsUpcoming EarningsGap DownDTDynatrace4.9638 of 5 stars$48.50-1.8%$62.63+29.1%-0.1%$14.89B$1.70B29.755,200Positive NewsAnalyst DowngradeTEMTempus AI1.6117 of 5 stars$75.90-5.7%$67.64-10.9%+27.8%$13.99B$693.40M0.002,400Analyst ForecastGap DownPAYCPaycom Software4.2697 of 5 stars$230.65-1.4%$234.36+1.6%+39.5%$13.54B$1.88B31.217,306Positive NewsYMMFull Truck Alliance3.9916 of 5 stars$12.84+0.9%$15.00+16.8%+80.0%$13.31B$1.54B22.937,185Positive NewsDOCSDoximity3.2338 of 5 stars$66.43-1.9%$66.21-0.3%+84.7%$12.44B$589.64M66.43890Positive NewsSNAPSnap3.0106 of 5 stars$7.01-2.6%$34.16+387.3%-23.5%$12.17B$5.36B-21.914,911IONQIonQ2.006 of 5 stars$38.67-2.8%$45.00+16.4%+476.1%$11.81B$43.07M0.00100Gap DownMBLYMobileye Global3.7095 of 5 stars$13.81-2.4%$19.67+42.4%-1.9%$11.53B$1.65B-3.783,900News CoveragePositive News Related Companies and Tools Related Companies Duolingo Alternatives Docusign Alternatives Dynatrace Alternatives Tempus AI Alternatives Paycom Software Alternatives Full Truck Alliance Alternatives Doximity Alternatives Snap Alternatives IonQ Alternatives Mobileye Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLBT) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
